Ameriprise’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
294,326
-4,464
| -1% | -$1.64K | ﹤0.01% | 3847 |
|
|
2025
Q1 | $77.4K | Sell |
298,790
-145,249
| -33% | -$37.6K | ﹤0.01% | 3875 |
|
|
2024
Q4 | $250K | Buy |
444,039
+3,550
| +0.8% | +$2K | ﹤0.01% | 3760 |
|
|
2024
Q3 | $264K | Buy |
440,489
+299,160
| +212% | +$179K | ﹤0.01% | 3670 |
|
|
2024
Q2 | $382K | Buy |
141,329
+121,026
| +596% | +$327K | ﹤0.01% | 3516 |
|
|
2024
Q1 | $104K | Buy |
+20,303
| New | +$104K | ﹤0.01% | 3780 |
|